Black Rock Inc. Biora Therapeutics, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2022 Aug 12, 2022	SELL	$0.56 - $1.22 $19,728 - $42,979	-35,229 Reduced 2.12%	1,626,853 $1.14 Million
Q1 2022 May 12, 2022	SELL	$1.11 - $2.25 $2,547 - $5,163	-2,295 Reduced 0.14%	1,662,082 $1.93 Million
Q4 2021 Feb 10, 2022	BUY	$1.35 - $4.89 $1.66 Million - $6.03 Million	1,232,182 Added 285.1%	1,664,377 $3.48 Million
Q3 2021 Nov 09, 2021	BUY	$0.67 - $3.41 $552 - $2,813	825 Added 0.19%	432,195 $657,000
Q2 2021 Aug 11, 2021	BUY	$2.11 - $4.93 $910,190 - $2.13 Million	431,370 New	431,370 $1.54 Million

Others Institutions Holding BIOR

# of Institutions

2

Shares Held

890

Call Options Held

0

Put Options Held

0

About BIORA THERAPEUTICS, INC.

Ticker BIOR
Exchange NASDAQ
Shares Outstandng 186,623,605
Market Cap $312M
Description
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ing...

More about BIOR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.